Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Paul J. Clancy
“We are pleased to welcome Paul Clancy to our Board and look forward to the addition of Ian Bell in December,” said Kevin Conroy, Chairman of the Board of Align Technology. “Paul and Ian bring significant global healthcare, financial, innovation and operational leadership experience that will complement the strengths of Align’s Board. Paul’s deep financial and strategic leadership in the biopharmaceutical industry, together with Ian’s broad perspective across commercial, manufacturing, quality and regulatory operations and his experience leading innovation-driven businesses, will be valuable as we continue to execute our strategy and drive long-term growth.”
Mr. Clancy brings more than 30 years of strategic, financial and operational leadership experience, primarily in the biotechnology and pharmaceutical industries. He served as Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals from July 2017 to October 2019 and remained a Senior Advisor to the company until July 2020. Previously, he served as Executive Vice President and Chief Financial Officer of Biogen from 2007 to 2017, where he led the company's financial strategy through a decade of growth. After joining Biogen in 2001 as Vice President of
Mr. Bell currently serves as Senior Vice President and Chief Operating Officer of Alcon, where he oversees the company's commercial, manufacturing, quality, and regulatory operations. Prior to assuming this role in 2024, he served as President, Global Business & Innovation, leading product development across Alcon's surgical, vision care, and digital health businesses. Previously, he served as President, International and President of Alcon's
Mr. Clancy and Mr. Bell will be included in the company’s slate of director nominees in the proxy statement for Align’s 2027 Annual Meeting of Shareholders. Following the appointments of Messrs. Clancy and Bell, the Board will be composed of 13 directors until December 31, 2026, when the previously announced retirement of Mr. C. Raymond Larkin, Jr. will reduce the number of directors to 12.
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 307 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 24.2 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.
For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.
Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118992581/en/
Align Technology
Madelyn Valente
(909) 833-5839
mvalente@aligntech.com
Zeno Group
Sarah Karlson
(828) 551-4201
sarah.karlson@zenogroup.com
Source: Align Technology, Inc.